Revenue: The sum of all revenue fields included for a company's operating activities.
Cogent Biosciences, Inc. (COGT) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-71.99M |
|
-- |
|
-- |
|
$74.93M |
|
$-74.93M |
|
$2.95M |
|
$-71.99M |
|
$-71.99M |
|
$-71.99M |
|
$-71.99M |
|
$-71.99M |
|
$-71.99M |
|
$-74.93M |
|
$-75.25M |
|
113.31M |
|
113.31M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$252.88M |
|
$6.45M |
|
$30.91M |
|
$283.80M |
|
$49.32M |
|
-- |
|
$15.48M |
|
$64.80M |
|
$110.83M |
|
$219.00M |
|
$219.00M |
|
113.86M |
|
| Cash Flow Statement Financials | |
$-66.51M |
|
$69.38M |
|
$24.97M |
|
$98.17M |
|
$126.00M |
|
$27.84M |
|
$10.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-67.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-64.95% |
|
-32.87% |
|
-25.37% |
|
-32.87% |
|
$1.92 |
|
$-0.59 |
|
$-0.59 |
|